LYB
55
-2
R
57
-2
ZTS
43
-6
HCP
56
2
AN
49
-5
RRC
49
3
KO
44
-5
USB
43
-4
PRU
62
-2
CL
59
-2
ES
55
-7
TXN
46
3
EXR
46
-2
MCK
45
-3
WAT
50
-5
GME
59
-2
MA
62
-2
FE
44
-2
QCOM
53
2
HSIC
37
-5
LYB
55
-2
R
57
-2
ZTS
43
-6
HCP
56
2
AN
49
-5
RRC
49
3
KO
44
-5
USB
43
-4
PRU
62
-2
CL
59
-2
ES
55
-7
TXN
46
3
EXR
46
-2
MCK
45
-3
WAT
50
-5
GME
59
-2
MA
62
-2
FE
44
-2
QCOM
53
2
HSIC
37
-5
Financhill
Back

Summit Therapeutics Stock Predictions

AI Tech Innovator Poised for Strategic Buyouts Invest Now

Learn More
Sell
47

SMMT
Summit Therapeutics

Last Price:
18.62
Seasonality Move:
25.3%

7 Day Trial

ALL ACCESS PASS

$ 7

Supercharge Your Portfolio with This High-Traction AI Startup

Learn More

Summit Therapeutics Stock Forecast

  • Over the next 52 weeks, Summit Therapeutics has on average historically risen by 124.6% based on the past 9 years of stock performance.
  • Summit Therapeutics has risen higher in 5 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%
  • Is Summit Therapeutics Stock Undervalued?
    The current Summit Therapeutics [SMMT] share price is $19.54. The Score for SMMT is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • SMMT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Summit Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Summit Therapeutics has on average historically risen by 124.6% based on the past 9 years of stock performance.

Summit Therapeutics Stock Rating

Sell
47
Summit Therapeutics (SMMT) is a Sell

Is Summit Therapeutics overpriced?

  • Summit Therapeutics has risen higher in 5 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%

Summit Therapeutics Stock Price History

Is SMMT stock going to rise?

  • The current trend is moderately bearish and SMMT is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
smmttx.com

52-Week Data

52-Week High:
33.89
52-Week Low:
1.64

Prediction Charts

Market Cap:
14.36B
Price in USD:
19.54
Volume:
4.12M
Beta:
-0.26

Technical Analysis

SMA50:
15.95
SMA100:
11.59
SMA200:
7.71
52-Wk Change:
1003.95%

Stock Predictions

  • Is Summit Therapeutics stock public?
    Yes, Summit Therapeutics is a publicly traded company.
  • What is the Summit Therapeutics stock quote today?
    The Summit Therapeutics stock price is 19.54 USD today.
  • How to buy Summit Therapeutics stock online?
    You can buy Summit Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Sep-13 27.50 31.93 33.60 27.41
Sep-16 32.52 29.48 33.89 28.73
Sep-17 28.44 26.22 29.09 25.61
Sep-18 26.17 24.55 26.67 23.96
Sep-19 25.09 23.16 25.13 22.93
Sep-20 23.16 24.39 24.95 22.96
Sep-23 24.40 21.91 25.50 20.85
Sep-24 21.91 23.99 24.00 21.04
Sep-25 24.82 22.64 24.84 22.37
Sep-26 22.84 22.81 23.62 22.04
Sep-27 21.49 20.89 21.70 19.50
Sep-30 20.50 21.90 22.05 20.25
Oct-1 21.63 20.10 21.84 19.75
Oct-2 19.75 19.54 20.36 19.22

Summit Therapeutics Earnings

Summit Therapeutics Earnings Report: Per Share Summit Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Summit Therapeutics Forecast Revenue Growth

Summit Therapeutics Stock Analysis: Historical quarterly revenues per share for Summit Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.32 per share, and a decrease next year of $0.03 per share.

* Summit Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.